Global Active Pharmaceutical Ingredients CDMO Market Share

Statistics for the 2023 & 2024 Global Active Pharmaceutical Ingredients CDMO market share, created by Mordor Intelligence™ Industry Reports. Global Active Pharmaceutical Ingredients CDMO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Active Pharmaceutical Ingredients CDMO Industry

The active pharmaceutical ingredients CDMO market is fragmented and consists of several major players. In terms of market share, a few major players dominate the market. A few of them are Cambrex Corporation, Patheon (Themo Fisher Scientific Inc.), Recipharm AB, Astorg (CordenPharma), Samsung Biologics, Lonza, Siegfried, Piramal Pharma Solutions, Abbvie Inc., and Catalent Inc.

The role of API manufacturers in the pharmaceutical supply chain is evolving in response to customers' newfound demands and increasing pressures from global competitors. Traditional generic firms are looking to China and India for bulk activities, while specialty pharmaceutical companies have generated new demands for more specialized capabilities than traditional generics require.

Active Pharmaceutical Ingredients CDMO Market Leaders

  1. Catalent, Inc.

  2. Cambrex Corporation

  3. Lonza Group

  4. Recipharm AB

  5. Astorg (Corden Pharma)

*Disclaimer: Major Players sorted in no particular order

Active Pharmaceutical Ingredients CDMO Market Concentration

API CDMO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)